It's been a busy and exciting summer for Diagonal! We recently moved out of an incubator space and into our very own office in Arsenal Yards, Watertown. The team has been hard at work setting up our new lab. What better way to celebrate and wrap up the summer than with a trip on the famous Boston Duck Tour!
About us
Diagonal Therapeutics is a biotech company pioneering a new approach to discovering and developing agonist antibodies. The Company's DIAGONAL platform combines proprietary computational and experimental techniques to overcome historical challenges associated with agonist antibody drug discovery. Diagonal's emerging pipeline – discovered using the DIAGONAL platform – has the potential to deliver life-changing therapies to patients including therapies for hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. For more information, please visit www.diagonaltx.com.
- Website
-
www.diagonaltx.com
External link for Diagonal Therapeutics
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Watertown, Massachusetts
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Oncology, Rare Disease, Immunology, Biotech, and Immunooncology
Locations
-
Primary
Get directions
Watertown, Massachusetts 02472, US
Employees at Diagonal Therapeutics
Updates
-
Thanks to BioCentury Inc.’s Danielle Golovin, Ph.D. for featuring us in this emerging company profile. Danielle and our CEO Alexey "Alex" Lugovskoy had a great discussion about how Diagonal Therapeutics is solving the historical challenge that has limited agonist antibody drug discovery. Our approach skillfully blends computational and experimental techniques to reproducibly find molecules that trigger the signaling of any receptor complex, thus creating new medicines for disorders where patients have limited or no treatment options. https://lnkd.in/enikPXYM
-
-
Dr. Philippe Marambaud’s work developing new preclinical models helps improve our understanding of HHT and test novel therapies. Congrats for being recognized as a Changemaker by Cure HHT!
The type of change within our reach is truly transformational. This June Awareness Month, stayed tuned as we spotlight changemakers whose work is leading to life-saving progress and hope for HHT patients everywhere -- like Dr. Philippe Marambaud. Learn more about how the models Dr. Marambaud has developed have spurred critical advancements for potential revolutionary therapeutic discoveries to treat HHT. Consider becoming a changemaker yourself with a donation today: https://lnkd.in/gSUUZy_N
-
While new treatments are critical, it’s also imperative to raise awareness about HHT to improve diagnosis for this condition. #HHTAwarenessMonth #HHTAwareness
Awareness saves lives. Consider becoming an HHT Changemaker with a gift this June Awareness Month. Every donation -- no matter the size -- fuels our work to spread awareness, increase access to care, and improve how HHT is treated and cared for. To this day, it's estimated that up to 90% of HHT patients remain undiagnosed. Let's spread the word this June! Sometimes, a nosebleed is so much more than "just a nosebleed." Donate today: https://lnkd.in/gZw6Ps_P
-
-
June is hereditary hemorrhagic telangiectasia (HHT) awareness month. HHT is a genetic orphan disease that affects more than 150,000 patients in the US and EU. The disease causes frequent bleeding that leads to transfusion-dependent anemia in the majority of patients. It's underdiagnosed and often misunderstood, which is why awareness is so important! At Diagonal, we are advancing therapies that we believe can treat the underlying cause of HHT. Throughout June, join us in raising awareness of HHT and learn more by visiting: www.curehht.org #HHTAwarenessMonth #HHTAwareness
-
-
Our CEO Alexey "Alex" Lugovskoy will participate at this year’s Jefferies Global Healthcare Conference June 4-6 in New York City. We look forward to seeing you in NY!
-
-
We’re looking forward to being onsite at the BIO International Convention in San Diego this June. Interested in learning more about our agonist antibody platform? Book a meeting now. Search ‘Diagonal Therapeutics’ in the partnering platform or get in touch through our website to book a meeting https://lnkd.in/gHuD7V6K #partnering #biotech #agonistantibodies #BIO2024
-
-
Our platform enables us to rapidly discover agonist antibodies against any receptor complex of interest in a timeframe unimaginable using legacy approaches. We’ve already successfully developed antibodies against 4 structurally distinct receptor families. Watch the short animation to learn more. https://lnkd.in/ene8XC8F #agonistantibodies #antibodies #drugdiscovery
-
Diagonal Therapeutics reposted this
On a mission to fundamentally change how agonist antibody therapies are developed, Diagonal Therapeutics just launched with $128 million in financing, including participation from Lightspeed. We look forward to witnessing the team pave the path to tackling the underlying causes of severely debilitating diseases and, ultimately, changing lives. https://lnkd.in/eDcwaZgc
-
-
Diagonal Board Chair and Partner at Atlas Venture, Michael Gladstone, discusses our unique approach to activating deficient signaling pathways with agonist antibodies and the potential it holds to treat severely debilitating diseases. https://lnkd.in/efCyCjU6 #venturecapital #startup #companylaunch #antibodies Diagonal Therapeutics
-